The AirCurveTM 10 CS PaceWaveTM is indicated to stabilise the ventilation of adult patients exhibiting central sleep apnoea (CSA) in all its forms. In CSA, normal breathing can be affected by reduced sensitivity to abnormal oxygen levels in the blood, leading to over-compensation in signals sent from the brain to the lungs to slow down (reduce tidal volumes) or speed up (increase tidal volumes) and breath rates and sizes. CSA is different to obstructive sleep apnoea, which is caused by a blockage in the upper airway. Your clinician will advise you if you have CSA. Some people have both types of sleep apnoea and this device will treat both. AirCurve 10 CS PaceWave is an adaptive servo-ventilator (ASV) with two modes: ASVAuto and ASV. The clinically proven PaceWave algorithm is available in the AirCurve 10 CS PaceWave device.
ASVAuto mode adapts to your ventilatory and upper airway stability needs on a breath-by-breath basis. By treating breathing disorders with auto-adjusting pressure support and upper airway obstruction with auto-adjusting expiratory positive airway pressure (EPAP), it rapidly stabilises respiration.
In the PaceWave ASV mode, the EPAP is manually adjusted by your clinician to set the optimal fixed EPAP to keep your airway open.